NDC 63323-282

Clindamycin

Clindamycin Phosphate

Clindamycin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Clindamycin Phosphate.

• Product ID: 63323-282_0303c92f-8410-4f12-b31f-f98ef869ecb4
• NDC: 63323-282
• Product Type: Human Prescription Drug
• Proprietary Name: Clindamycin
• Generic Name: Clindamycin Phosphate
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2009-11-22
• Marketing Category: ANDA / ANDA
• Application Number: ANDA065346
• Labeler Name: Fresenius Kabi USA, LLC
• Substance Name: CLINDAMYCIN PHOSPHATE
• Active Ingredient Strength: 150 mg/mL
• Pharm Classes: Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 63323-282-60

1 VIAL in 1 BOX (63323-282-60) > 60 mL in 1 VIAL

• Marketing Start Date: 2009-11-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63323-282-60 [63323028260]

Clindamycin INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA065346
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-11-22

NDC 63323-282-02 [63323028202]

Clindamycin INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA065347
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-11-22
• Marketing End Date: 2019-11-30

NDC 63323-282-04 [63323028204]

Clindamycin INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA065347
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-11-22

NDC 63323-282-06 [63323028206]

Clindamycin INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA065347
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-11-22
• Marketing End Date: 2019-10-31

Drug Details

Active Ingredients

Ingredient	Strength
CLINDAMYCIN PHOSPHATE	150 mg/mL

OpenFDA Data

• SPL SET ID: b8133f76-8880-4b91-a451-b3f831ad6853
• Manufacturer:
  • Fresenius Kabi USA, LLC
• UNII:
  • EH6D7113I8
• RxNorm Concept Unique ID - RxCUI:
  • 1737244
  • 205964
  • 1737578
  • 1737581

Pharmacological Class

• Decreased Sebaceous Gland Activity [PE]
• Lincosamide Antibacterial [EPC]
• Lincosamides [CS]

NDC Crossover Matching brand name "Clindamycin" or generic name "Clindamycin Phosphate"

NDC	Brand Name	Generic Name
71872-7088	Clindamycin	Clindamycin
71872-7123	Clindamycin	Clindamycin
71872-7089	Clindamycin	Clindamycin
17478-121	Clindamycin	Clindamycin
17478-122	Clindamycin	Clindamycin
17478-120	Clindamycin	Clindamycin
25021-115	Clindamycin	Clindamycin
47781-459	Clindamycin	Clindamycin
47781-462	Clindamycin	Clindamycin
47781-461	Clindamycin	Clindamycin
47781-465	Clindamycin	Clindamycin
47781-460	Clindamycin	Clindamycin
47781-464	Clindamycin	Clindamycin
47781-463	Clindamycin	Clindamycin
52584-814	CLINDAMYCIN	CLINDAMYCIN
52584-815	CLINDAMYCIN	CLINDAMYCIN
52584-816	CLINDAMYCIN	CLINDAMYCIN
55154-2828	Clindamycin	Clindamycin
63323-282	Clindamycin	Clindamycin
67457-814	Clindamycin	Clindamycin
67457-815	Clindamycin	Clindamycin
67457-816	Clindamycin	Clindamycin
71872-7168	Clindamycin	Clindamycin
52584-090	Clindamycin	Clindamycin
67457-817	Clindamycin	Clindamycin
51662-1437	CLINDAMYCIN	CLINDAMYCIN
0009-0302	Cleocin Phosphate	clindamycin phosphate
0009-0602	Cleocin Phosphate	clindamycin phosphate
0009-0728	Cleocin Phosphate	clindamycin phosphate
0009-0775	Cleocin Phosphate	clindamycin phosphate
0009-0870	Cleocin Phosphate	clindamycin phosphate